All posts tagged "Dr Reddy"
-
1.1KNewsDr Reddy’s suffers major setback as net dips by 77% in Q1, announces Q1 FY17 Financial Results
Dr Reddy’s Laboratories (DRL) has suffered major setback and its consolidated net profit for the first quarter ended June 2016 declined sharply...
- 1.2KNews
Dr Reddy’s recalls 9,330 bottles of Sirolimus tablets in US
Pharma major Dr Reddy’s Laboratories is recalling 9,330 bottles of Sirolimus tablets, used for prevention of organ rejection after kidney transplant, in...
- 1.2KNews
Dr. Reddy’s to acquire product portfolio from TEVA for US Market
Dr. Reddy’s Laboratories has entered into a definitive agreement with Teva Pharmaceutical Industries Ltd. and an affiliate of Allergan plc to acquire...
- 1.4KNews
Dr Reddy’s acquires six OTC brands from Ducere Pharma
Dr. Reddy’s Laboratories Ltd has announced the acquisition of an eminent portfolio of over-the-counter (OTC) brands in the cough-and-cold, pain, and dermatology...
- 1.1KMedical Technology
Dr Reddy’s Laboratories and XenoPort Enter Into a U.S. Licensing Agreement for XP23829
Dr. Reddy’s Laboratories and XenoPort, Inc. announced today that they have entered into a license agreement pursuant to which Dr. Reddy’s Laboratories...
- 1.2KNews
Promius Pharma Receives FDA Approval for Sernivo (betamethasone dipropionate) Spray, 0.05%
Dr. Reddy’a announced today that its US subsidiary, Promius Pharma, LLC, U.S. has received approval for Sernivo (betamethasone dipropionate) Spray, 0.05% from...
- 7.3KNews
Dr. Reddy’s Laboratories Ltd. Receives FDA approval for ZEMBRACETM SymTouch Injection
Dr. Reddy’s Laboratories announced today that the U.S. Food and Drug Administration (FDA) has approved ZEMBRACE SymTouch (sumatriptan succinate) injection, a drug-device...
- 1.1KNews
Indian pharmaceutical market may touch $55 bn by 2020 says GlobalData
The pharmaceuticals market in India, valued at $20 billion in 2015, is set to soar to $55 billion by 2020, representing an...
- 1.0KNews
Dr. Reddy’s acquires IP rights of generic anti-coagulant fondaparinux from Alchemia
Dr. Reddy’s Laboratories today announced that it has completed the purchase of worldwide exclusive intellectual property rights for fondaparinux sodium, its generic...
- 1.0KNews
Dr. Reddy in strategic alliance with Biocodex inks to market their flagship products in Romania
Dr. Reddy’s Laboratories has entered into a strategic alliance with Biocodex to market and distribute Biocodex products in the Romanian market. Biocodex...
